Abbott Laboratories Stock Outlook: Is Wall Street Bullish or Bearish?

With a market cap of $218.8 billion, Abbott Laboratories (ABT) is a global healthcare leader with a diversified portfolio spanning medical devices, diagnostics, nutrition, and branded generic pharmaceuticals. The North Chicago, Illinois-based company is best known for innovations like its FreeStyle Libre glucose monitoring system. Abbott plays a major role in chronic disease management, lab testing technologies, and specialized nutrition with brands such as Ensure, Pedialyte, and Similac. 

Over the past year, ABT shares have soared 5.8%, trailing the broader S&P 500 Index ($SPX), which has gained 17.5%. Moreover, ABT stock has risen 10.1% on a YTD basis, compared to SPX's 15.6% rise.